Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial - Pawade, Tania A.; Doris, Mhairi K.; Bing, Rong; White, Audrey C.; Forsyth, Laura; Evans, Emily; Graham, Catriona; Williams, Michelle C.; van Beek, Edwin J.R.; Fletcher, Alison; Adamson, Philip D.; Andrews, Jack P.M.; et al. (Circulation (New York, N.Y.), 2021)
Keywords: Aged; Aged, 80 and over; Alendronate - therapeutic use; Aortic Valve Stenosis - diagnostic imaging; Aortic Valve Stenosis - drug therapy; Aortic Valve Stenosis - metabolism; Bone Density Conservation Agents - therapeutic use; Denosumab - therapeutic use; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Original s; Positron Emission Tomography Computed Tomography; Treatment Outcome; Vascular Calcification - diagnostic imaging; Vascular Calcification - drug therapy; Vascular Calcification - metabolism; alendronate; computed tomography, X-ray; aortic stenosis; denosumab; calcium signaling